Mircera
The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
Name | Mircera |
---|---|
Active Substance | metoksi polietilenglikol-epoetin beta |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
ATC Code | B03XA03 |
Medicinal product marketed in the Croatia | Da |
Summary of product characteristics (SmPC), labelling and package leaflet (PL) | download |
Link to the European Medicines Agency's (EMA) product information | download |
Link to the European Commission's (EC) decisions | download |
Educational materials for healthcare professionals |
Vodič za liječnike, verzija 2 |
Direct Healthcare Professional Communication
Name | Date | Download |
---|---|---|
Pismo zdravstvenim radnicima o novim upozorenjima o teškim kožnim nuspojavama lijekova koji sadrže humane epoetine | 29.09.2017 | Amgen d.o.o., Pfizer Croatia d.o.o., Pliva Hrvatska d.o.o., Roche d.o.o. i Sandoz d.o.o. |